Literature DB >> 24363035

Quality of life in adult patients with glycogen storage disease type I: results of a multicenter italian study.

Annalisa Sechi1, Laura Deroma, Sabrina Paci, Annunziata Lapolla, Francesca Carubbi, Alberto Burlina, Miriam Rigoldi, Maja Di Rocco.   

Abstract

BACKGROUND: Glycogen storage disease type I (GSD I) is a chronic metabolic disease that requires a lifelong strict dietetic treatment to avoid hypoglycemia and can lead to severe complications during adult age. Impaired quality of life (QoL) has been reported in affected children, but this aspect has not been previously investigated in adults.
OBJECTIVE: To assess QoL in adult patients with GSD I. PATIENTS AND METHODS: Italian patients with GSD type Ia and Ib, who were 16 years or older, were asked to complete the SF-36 questionnaire, assessing their QoL. Data on demographic characteristics and clinical history were collected from clinical records and interviews.
RESULTS: Thirty-eight patients (22 females, 16 males; 27 with GSD Ia, 11 with GSD Ib, median age 26.5 years) completed the SF-36 questionnaire. Overall, when compared to normal values, patients with GSD I had lower median scores in general health perception and social functioning, but better median scores for bodily pain and mental health. Patients with GSD Ib had a lower Z-score than GSD Ia patients for emotional health problems. Male patients showed better Z-scores in physical functioning, general health perception, and social functioning when compared to females. Emotional health problems Z-score was lower in nephropathic patients.
CONCLUSION: QoL can be impaired in adult patients with GSD I. The results of this study show that patients with GSD type Ib, women, and those with renal complications are more likely to experience a poorer QoL.

Entities:  

Year:  2013        PMID: 24363035      PMCID: PMC4213326          DOI: 10.1007/8904_2013_283

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  18 in total

Review 1.  Glycogen storage diseases.

Authors:  Joseph I Wolfsdorf; David A Weinstein
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).

Authors:  Jan Peter Rake; Gepke Visser; Philippe Labrune; James V Leonard; Kurt Ullrich; G Peter A Smit
Journal:  Eur J Pediatr       Date:  2002-08-22       Impact factor: 3.183

3.  Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I.

Authors:  G Visser; J P Rake; J Fernandes; P Labrune; J V Leonard; S Moses; K Ullrich; G P Smit
Journal:  J Pediatr       Date:  2000-08       Impact factor: 4.406

Review 4.  Personality and coping.

Authors:  Charles S Carver; Jennifer Connor-Smith
Journal:  Annu Rev Psychol       Date:  2010       Impact factor: 24.137

5.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

6.  Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.

Authors:  J I Wolfsdorf; J F Crigler
Journal:  J Pediatr Gastroenterol Nutr       Date:  1999-08       Impact factor: 2.839

7.  Psychosocial functioning in youth with glycogen storage disease type I.

Authors:  Eric Storch; Mary Keeley; Lisa Merlo; Marni Jacob; Catherine Correia; David Weinstein
Journal:  J Pediatr Psychol       Date:  2008-02-23

Review 8.  Glycogen storage disease in adults.

Authors:  G M Talente; R A Coleman; C Alter; L Baker; B I Brown; R A Cannon; Y T Chen; J F Crigler; P Ferreira; J C Haworth; G E Herman; R M Issenman; J P Keating; R Linde; T F Roe; B Senior; J I Wolfsdorf
Journal:  Ann Intern Med       Date:  1994-02-01       Impact factor: 25.391

9.  Growing older: the adult metabolic clinic.

Authors:  P J Lee
Journal:  J Inherit Metab Dis       Date:  2002-05       Impact factor: 4.982

10.  Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU).

Authors:  Eva Simon; Martin Schwarz; Judith Roos; Nico Dragano; Max Geraedts; Johannes Siegrist; Gudrun Kamp; Udo Wendel
Journal:  Health Qual Life Outcomes       Date:  2008-03-26       Impact factor: 3.186

View more
  8 in total

1.  Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre.

Authors:  Rebecca K Halligan; R Neil Dalton; Charles Turner; Katherine A Lewis; Helen R Mundy
Journal:  Orphanet J Rare Dis       Date:  2022-05-12       Impact factor: 4.303

2.  Recoverable, Record-High Lactic Acidosis in a Patient with Glycogen Storage Disease Type 1: A Mixed Type A and Type B Lactate Disorder.

Authors:  Yonatan Oster; Isaiah D Wexler; Samuel N Heyman; Elchanan Fried
Journal:  Case Rep Med       Date:  2016-11-16

3.  A retrospective study of eating and psychosocial problems in patients with hepatic glycogen storage diseases and idiopathic ketotic hypoglycemia: Towards a standard set of patient-reported outcome measures.

Authors:  Annieke Venema; Fabian Peeks; Marlies de Bruijn-van der Veen; Foekje de Boer; Marieke J Fokkert-Wilts; Charlotte M A Lubout; Bibi Huskens; Eric Dumont; Sandra Mulkens; Terry G J Derks
Journal:  JIMD Rep       Date:  2021-10-10

Review 4.  Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs.

Authors:  Terry G J Derks; David F Rodriguez-Buritica; Ayesha Ahmad; Foekje de Boer; María L Couce; Sarah C Grünert; Philippe Labrune; Nerea López Maldonado; Carolina Fischinger Moura de Souza; Rebecca Riba-Wolman; Alessandro Rossi; Heather Saavedra; Rupal Naik Gupta; Vassili Valayannopoulos; John Mitchell
Journal:  Nutrients       Date:  2021-10-27       Impact factor: 5.717

5.  Involvement of endocrine system in a patient affected by glycogen storage disease 1b: speculation on the role of autoimmunity.

Authors:  Daniela Melis; Roberto Della Casa; Francesca Balivo; Giorgia Minopoli; Alessandro Rossi; Mariacarolina Salerno; Generoso Andria; Giancarlo Parenti
Journal:  Ital J Pediatr       Date:  2014-03-19       Impact factor: 2.638

Review 6.  Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: a scoping review.

Authors:  Carlota Pascoal; Sandra Brasil; Rita Francisco; Dorinda Marques-da-Silva; Agnes Rafalko; Jaak Jaeken; Paula A Videira; Luísa Barros; Vanessa Dos Reis Ferreira
Journal:  Orphanet J Rare Dis       Date:  2018-11-28       Impact factor: 4.123

7.  A retrospective in-depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management.

Authors:  Fabian Peeks; Irene J Hoogeveen; R Lude Feldbrugge; Rob Burghard; Foekje de Boer; Marieke J Fokkert-Wilts; Melanie M van der Klauw; Maaike H Oosterveer; Terry G J Derks
Journal:  J Inherit Metab Dis       Date:  2021-05-05       Impact factor: 4.982

8.  Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report.

Authors:  Alessandro Rossi; Erasmo Miele; Simona Fecarotta; Maria Veiga-da-Cunha; Massimo Martinelli; Carmine Mollica; Maria D'Armiento; Enza Mozzillo; Pietro Strisciuglio; Terry G J Derks; Annamaria Staiano; Giancarlo Parenti
Journal:  Ital J Pediatr       Date:  2021-07-02       Impact factor: 2.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.